Using double immunofluorescent labeling with antibodies to CD34 and Cav-1, Yang et al. [128] determined that the microvascular density values were also significantly higher in Cav-1-positive than in Cav-1-negative prostate cancer tumors. The gene discussed is CAV1; the disease is Familial prostate cancer.